Description: Rafael Holdings Inc, through its subsidiaries, is a clinical stage, oncology-focused pharmaceutical company committed to the development and commercialization of therapies that exploit the metabolic differences between normal cells and cancer cells.
Home Page: www.rafaelholdings.com
RFL Technical Analysis
520 Broad Street
Newark,
NJ
07102
United States
Phone:
212 658 1450
Officers
| Name | Title |
|---|---|
| Mr. Howard S. Jonas | Founder & Chairman |
| Mr. William Conkling | Chief Exec. Officer |
| Mr. Patrick Fabbio M.B.A. | CFO & Pres |
| Ms. Barbara A. Ryan | Investor Relations Officer |
| Mr. David A. Polinsky Esq. | Chief of Staff |
| Mr. Gus Kodersha | Chief Technical Operations Officer |
| Dr. Rick Ewing | Head of Drug Discovery |
| Ms. Joyce J. Mason Esq. | Corp. Sec. |
Exchange: NYSE
Country: US : United States of America
Currency: US Dollar ($)
| GIC Sector: | Real Estate |
|---|---|
| GIC Group: | Real Estate |
| GIC Industry: | Real Estate Management & Development |
| GIC Sub-Industry: | Real Estate Operating Companies |
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 0 |
| Price-to-Book MRQ: | 0.4602 |
| Price-to-Sales TTM: | 149.8847 |
| IPO Date: | 2018-03-26 |
| Fiscal Year End: | July |
| Full Time Employees: | 22 |